Plasmalogens are synthesized in a part of the cell called the peroxisome. Peroxisome function is known to decline with age, and is likely the contributing factor for the reduced levels observed in the aging population. By providing the body with the proper synthetic peroxisomal building blocks, the body can bypass the deficiency and replenish its plasmalogen levels.
We often associate therapeutics with chemicals or drugs that are used to treat diseases after they develop. Our therapeutics are different. They are designed to correct underlying metabolic imbalances, even before symptoms appear.